CAS: 305-03-3; 4-(4-(Bis(2-Chloroethyl)Amino)Phenyl)Butanoic Acid

该化合物是一种主要用于治疗慢性淋巴细胞白血病(CLL)和某些淋巴瘤的化疗的氮芥子碱酯剂.作为甲胺的衍生物,它通过与DNA形成共价联系发挥作用,导致DNA复制和转录的交叉联系和抑制.它的口服生物利用率和相对缓慢的代谢许可允许方便的剂量疗法,使之适合长期管理.氯氨基因其针对淋巴组织有选择的活动而特别受到重视,它比更广泛的斑点碳酸剂减少了系统性毒性.它具有牢固的功效和可管理的副作用,几十年来使它成为了血解恶性疗法的基石.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品











合成工艺路线路线简述

  • 合成目标产物 Chlorambucil 主要起始原料 2,2-Dimethyl-1,3-Dioxane-4,6-Dione And Benzeneacetaldehyde, 4-[bis(2-Chloroethyl)Amino]-
  • (文献来源)合成步骤主要原料 2,2-Dimethyl-1,3-Dioxane-4,6-Dione 和 Benzeneacetaldehyde, 4-[bis(2-Chloroethyl)Amino]-
4-(4-氨基苯)丁酸甲酯置于盐酸,溶剂黄146,三氯氧磷体系中,用 甲苯 作为反应溶剂,化学反应生成 苯丁酸氮芥
参考文献:Synthesis And Pharmacokinetic Profile Of A Quaternary Ammonium Derivative Of Chlorambucil,A Potential Anticancer Drug For The Chemotherapy Of Chondrosarcoma
标题:Synthesis And Pharmacokinetic Profile Of A Quaternary Ammonium Derivative Of Chlorambucil,A Potential Anticancer Drug For The Chemotherapy Of Chondrosarcoma
摘要:As A Part Of Our Targeting Program Based On The Affinity Of The Quaternary Ammonium Moiety For Cartilage,Our Objective Was To Develop More Selective Anticancer Drugs Towards Chondrosarcoma That Would Concentrate In This Malignant Cartilaginous Tissue And So Improve The Therapeutic Index Through A Reduction Of Side Effects. For This Purpose We Have Synthesized And Labeled With C-14 A Quaternary Ammonium (Qa) Derivative Of Chlorambucil. Biological Studies Performed In Rats Showed That [c-14]-Cqa And [c-14]-Chlorambucil Exhibited Different Pharmacokinetic Profiles. The Blood Elimination Of [c-14]-Cqa Was Faster Than That Of Parent Compound. [c-14]-Cqa Was Principally Excreted By The Fecal Way. However,Until 15 Min After Administration,Levels Of Radioactivity Were Measured In Cartilaginous Tissues Of Rats Given [c-14]-Cqa Which Was Not The Case For The Rats Which Had Received [c-14]-Chlorambucil. Although Rates Of Radioactivity Were Quantified Only During 15 Min,These Results Prove That The Functionalization Of Chlorambucil By A Quaternary Ammonium Group Allows The Molecule To Be Carried Selectively To Cartilaginous Tissues. (C) 2003 Elsevier Ltd. All Rights Reserved.
DOI:10.1016/j.Bmc.2003.09.006

海关参考信息

专利信息


专利号:US-2004242897-A1
优先权日:2002-07-31
标题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-2012177593-A1
优先权日:2009-07-20
标 题 :Synthesis of dendrimer conjugates
发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

专利号:WO-2004011474-A1
优先权日:2002-07-31
标题:Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-6653468-B1
优先权日:2002-07-31
标 题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
权利人:ISIS PHARMACEUTICALS INC
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-7816544-B2
优先权日:2004-03-23
标 题:Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species
发明人:JONES II GUILFORD; GERARD BAUDOUIN; PORCO JR JOHN A
权利人:UNIV BOSTON
摘要:The present invention provides new strategies for the synthesis of compounds of the rocaglamide family and related natural products. In particular, the new biomimetic synthetic approach involves photochemical generation of an oxidopyrylium species from a 3-hydroxychromone derivative followed by 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile. This approach can be used for the formation of adducts containing an aglain core structure. Methods for the conversion of aglain core structures to aglain, rocaglamide and forbaglin ring systems are also provided. The present invention also relates to the use of rocaglamide/aglain/forbaglin derivatives for the manufacture of medicaments for use in the treatment of cancer or cancerous conditions, disorders associated with cellular hyperproliferation, or NF-κB-dependent conditions.

专利号:US-2010137421-A1
优先权日:2006-11-08
标题 :Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
发明人:THEODORAKIS EMMANUEL; BATOVA AYSE
权利人:THEODORAKIS EMMANUEL; BATOVA AYSE
摘要:Provided herein are compounds that are inducers of apoptosis activators of caspases and pharmaceutically acceptable derivatives thereof. Also provided are methods of synthesis of the compounds and methods for treatment of diseases in which there is uncontrolled cell growth and spread of abnormal cells, such as cancers, by administering the compounds.
广州拓华化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.topworkchem.com
电话: 13544492387👤
📞广州拓华化工科技有限公司 ⚠️参考联系方式

销售电话:13544492387
邮箱:sales@topworkchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: National Toxicology Program. Chlorambucil. Rep Carcinog. 2011;12:90-1. 83(3):156-8. doi: 10.1159/000205195. (9):CD008714. doi: 10.1002/14651858.CD008714.pub2.
9:125-34. 35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29. Erratum in: J Clin Oncol. 2017 Jul 10;35(20):2342. 117(7):1466-1466.e1. doi: 10.1016/j.ophtha.2010.03.023. 11(2):121-9. doi: 10.1016/0305-7372(84)90004-5. 23(3-4):187-201. doi: 10.3109/10428199609054821. 18(6):721-728. doi: 10.2174/1567201817666201027122620.
11:III47-8.

合成参考文献


参考文献:10.1021/bm100007s
摘要:Pang Y, Zhu Q, Liu J, Wu J, Wang R, Chen S, Zhu X, Yan D, Huang W, Zhu B. Design and synthesis of cationic drug carriers based on hyperbranched poly(amine-ester)s. Biomacromolecules. 2010 Mar 08;11(3):575–82. doi: 10.1021/bm100007s.
参考文献:10.1007/s10549-005-9083-x
摘要:Trafalis DT, Geromichalos GD, Koukoulitsa C, Papageorgiou A, Karamanakos P, Camoutsis C. Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer. Breast Cancer Res Treat. 2006 May;97(1):17–31. doi: 10.1007/s10549-005-9083-x.
参考文献:10.1007/s11095-005-8924-y
摘要:Rodriguez-Tenreiro C, Alvarez-Lorenzo C, Rodriguez-Perez A, Concheiro A, Torres-Labandeira JJ. New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability. Pharm Res. 2006 Jan;23(1):121–30. doi: 10.1007/s11095-005-8924-y.
参考文献:10.1007/s00405-003-0654-3
摘要:Tauber S, Nerlich A, Lang S. MALT lymphoma of the paranasal sinuses and the hard palate: report of two cases and review of the literature. European Archives of Oto-Rhino-Laryngology. 2005 Dec 01;263(1):19–22. doi: 10.1007/s00405-003-0654-3.
摘要:López H, Neira J, Morales MA, Fabbri C, D'Agostino ML, Zitto T. [Saint Louis encephalitis virus in Buenos Aires city during the outbreak of dengue in 2009]. Medicina (B Aires). 2011;71(3):247–50.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知